Targeting Zfp36 to combat cardiac hypertrophy: Insights into ferroptosis pathways
Abstract Background Cardiac hypertrophy is a precursor to heart failure and represents a significant global cause of mortality, thereby necessitating timely and effective therapeutic interventions. Zinc finger protein 36 (Zfp36) is recognised as a critical regulator of ferroptosis; however, its role...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2025-03-01
|
| Saila: | Clinical and Translational Medicine |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/ctm2.70247 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
